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Looking Back, Looking Forward*Rajesh U. Shenoy, MD, Ira A. Parness, MDH ypoplastic left heart syndrome (HLHS), arare congenital heart anomaly, with a re-ported incidence of 266 per 1 million live
births, was reilluminated by Lev (1) and others (2,3)
in the 1950s, although descriptions of anatomic pa-
thology date back to the 1800s (4) and early 20th cen-
tury (5). Subsequent work by the New England
Regional Infant Cardiac Program (6) demonstrated
that although HLHS accounted for 7.5% of cases of
congenital heart disease cases, it contributed to 25%
of neonatal mortality within the ﬁrst week of life.
These data, along with improvements in the ﬁeld of
infant cardiac surgery spurred the development of
staged surgical management of neonatal HLHS at Bos-
ton Children’s Hospital. Dr. William Norwood ﬁrst re-
ported successful surgical palliation of this condition
in the early 1980s (7).
Advances in surgical technique, as well as changes
in perioperative management (8) and a regimented
approach to interstage monitoring (9), have dramati-
cally improved early survival rates, although early
survival remains challenging and variable between
centers (10). The classic Norwood procedure, subse-
quently modiﬁed, led to some concern regarding its
reliance on an aortopulmonary shunt to perfuse the
pulmonary circulation. The diastolic “steal” through
the shunt, competing with coronary ﬂow, formed the
theoretical basis for much of the high post-operative
morbidity and mortality experienced in many cen-
ters. Coronary perfusion impairment, excessive pul-
monary blood ﬂow, and obstruction to pulmonary*Editorials published in the Journal of the American College of Cardiology
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relevant to the contents of this paper to disclose.blood ﬂow were the most prevalent causes of death in
a review of 122 post-mortem cases after the Norwood
procedure at the Boston Children’s Hospital (11). In
the late 1990s, Sano et al. (12) revisited the concept of
placing a shunt from the right ventricular (RV)
outﬂow tract to the pulmonary artery conﬂuence
(the so-called “RVPAS”). They utilized a shunt of a
smaller caliber than had been used previously and
reported survival to hospital discharge in 92% of their
patients (12).
Although the initial experience with the RVPAS
seemed to validate its enthusiastic acceptance, con-
cerns soon emerged regarding the increased need for
shunt reintervention and progressive cyanosis
necessitating second-stage palliation at an earlier age
(13). The ventriculotomy implicit in the RVPAS
approach prompted fears that myocardial injury and/
or aneurysm formation at the ventriculotomy site
would have a negative impact on ventricular perfor-
mance in the functionally “single” right ventricle, ill-
designed to play the role of a systemic ventricle in the
ﬁrst place (13).
In North America, HLHS has an annual incidence of
approximately 2,000 cases; thus, any research
designed to assess efﬁcacy of treatment approaches
toward palliating HLHS demanded collaborative
studies involving multiple institutions. An appro-
priate model existed in the ﬁeld of pediatric
oncology, where collaborative studies and trials un-
der the auspices of the Children’s Oncology Group
have greatly advanced knowledge and treatment
modalities (14). The Pediatric Heart Disease Clinical
Research Network was established by the National
Heart, Lung, and Blood Institute in 2001 to help pro-
vide evidence-based medicine to improve the out-
comes of pediatric patients with cardiovascular
disease (15). The SVR (Single Ventricle Reconstruc-
tion) trial compared the outcomes of the ﬁrst stage
of palliation of HLHS on the basis of shunt type (16).
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2037At 12 months of age, patients in the RVPAS group
had higher transplantation-free survival than those
with the modiﬁed Blalock-Taussig shunt, but also
had more unintended interventions and complica-
tions. After 12 months, there was no difference in
transplantation-free survival between the 2 groups.SEE PAGE 2026The SVR Extension Study, published in this issue
of the Journal, represents the logical next stage in
the evolution of our understanding of the approach
to ﬁrst-stage palliation of HLHS (17). The centers
participating in the study are commended for their
success in continuing to accrue data in a signiﬁcant
number of the survivors. As expected by the authors,
survivors of the RVPAS approach had statistically sig-
niﬁcant larger RV diastolic volumes and lower RV
ejection fractions prior to the Fontan stage, although
the absolute magnitude of interim decline was rela-
tively small. Should these parameters continue to
decline over time, they might augur an increased risk
for death or transplant. However, if the 14-month in-
terval to Fontan reported here marks a plateau of
decline in function, the effect on outcome might be
minimal; so, further follow-up of these parameters and
other outcome measures in this cohort is crucial. In
addition, the role that residual aortic arch obstruction
(11) and tricuspid valve function (18) play in the
occurrence and progression of ventricular dysfunction
needs to be studied. As the authors note, echocardi-
ography is not the optimal modality for assessing the
chamber dimensions and systolic function of a com-
plex chamber like the right ventricle. The data from
this study could help determine the indications for
performing more accurate but expensive imaging
modalities like cardiac magnetic resonance imaging.
Although the endpoints of death or transplant
are clearly paramount, they are not the sole measures
of efﬁcacy of a particular treatment approach. For
example, neurodevelopmental outcomes in survivors
of the 3 stages of palliation of HLHS are the focus of
several studies (19). Although poor neurodevelop-
mental outcomes are multifactorial in origin, post-
operative hemodynamic instability and morbidity
might play an important role. An arm of the SVR
Extension Study will assess the physical ability,
behavior, health, and quality-of-life of survivors with
annual questionnaires between 3 and 6 years of age. Ifit turns out that survivors of the RVPAS have better
neurodevelopmental outcomes, the issue of deciding
the superior approach to stage I palliation might be
even thornier than expected.
Of course, as surgical strategies have evolved, one
is no longer restricted to the 2 surgical options
compared in this study. Many institutions have
adopted a “hybrid” strategy for ﬁrst-stage palliation
involving transcatheter stenting of the ductus arte-
riosus to maintain systemic perfusion, surgical
placement of external branch pulmonary artery bands
to prevent pulmonary over-circulation, and trans-
catheter atrial septoplasty when necessary. Centers
are increasingly reporting hybrid survival results
that match or surpass those from the traditional
Norwood stage I surgical approaches (20). The hybrid
approach’s attraction stems from the avoidance of
cardiopulmonary bypass and/or circulatory arrest in
the newborn, potentially yielding more stable post-
operative hemodynamics. Fetal and neonatal brain
magnetic resonance imaging suggests that the brain
in HLHS patients is less mature (21). Avoiding insult
from bypass and circulatory arrest, as well as from
post-operative hemodynamic instability, could theo-
retically improve neurodevelopmental outcomes,
although this has not been studied.
One cannot overstate the importance of the SVR
Extension Study in setting a new standard for
multicenter-based outcomes research in congenital
heart disease surgery. The authors are commended
for presenting unique and important data stemming
from the medium-term follow-up of patients from the
original cohort of the SVR study. Ongoing follow-up
of this cohort will yield important data upon which
pediatric heart specialists can base the choice of sur-
gical modality for initial HLHS palliation. Although
the ﬁeld is challenged by the continual evolution of
alternate surgical approaches such as the HLHS
“hybrid” approach—which will need to be addressed
in future studies—this study represents a notable step
forward in the quest for outcomes-based decision
making in this highly complex ﬁeld.
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